Covid vaccine trial stopped after woman developed spinal inflammatory disorder soon after receiving injection

The participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trial who suffered a “serious adverse event,” causing a global shutdown of the company’s entire phase-three trial, developed a spinal inflammatory disorder known as transverse myelitis.

Company CEO Pascal Soriot told JP Morgan and other investors over a conference call that the woman from the United Kingdom developed neurological symptoms consistent with this “rare” disease almost immediately following injection, though AstraZeneca insists that the experimental vaccine is not to blame.

There was actually an earlier cause of neurological damage caused by AstraZeneca’s experimental Wuhan coronavirus (COVID-19) vaccine that occurred back in July, but that was never reported. This individual developed a similar neurological condition that was later dubbed as multiple sclerosis, with AstraZeneca insisting that it had absolutely nothing to do with the vaccine.


[link to www.naturalnews.com (secure)]